| Trial registration number
|
NCT05951920 |
Full text link
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT05951920
|
First author
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
Odile LAUNAY, Pr
|
Contact
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
odile.launay@aphp.fr
|
Registration date
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
2023-07-19
|
Recruitment status
Last imported at : July 23, 2023, midnight
Source : ClinicalTrials.gov
|
Recruiting
|
Study design
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
nonRCT
|
Allocation
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
Non-randomized
|
Design
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
Single group assignment
|
Masking
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
Open label
|
Center
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
Prevention
|
Inclusion criteria
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
male or female aged 18 years and over included in coviboost 2
|
Exclusion criteria
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
hypersensitivity to lidocaine, to anaesthetics of the amide type or to any of the excipients
patient with recurrent porphyrias
|
Number of arms
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
Assistance Publique - Hôpitaux de Paris
|
Inclusion age min
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
France
|
Type of patients
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
Healthy volunteers
|
Severity scale
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
N/A
|
Total sample size
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
12
|
primary outcome
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
The Spike and/or RBD-specific germinal center B cell repertoire;The Spike and/or RBD-specific germinal center B cell response
|
Notes
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
Phase 1
|
Arms
Last imported at : July 20, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "nan", "treatment_id": 2618, "treatment_name": "Bnt162b2 ba.4/ba.5", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "", "treatment_id": 2757, "treatment_name": "Vidprevtyn beta", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}]
|